ODI Pharma: Update on progress in “Project Poland” and “Project Skin”
In January 2021 and February 2021, ODI Pharma AB (“ODI” or the “Company”) announced the decision to expand its current business with specialized, highly CBD-infused skin care products (“Project Skin”) and the application for Marketing Authorization of medicinal cannabis in Poland (“Project Poland”). The Company hereby updates on the development of these projects.Project Poland On 22[nd] of February 2021, the Company announced that its subsidiary ODI Pharma Polska Sp. z o.o. has finalized documentation and filed the application to obtain a marketing authorization for the sale of medicinal